Background: Advances in interventional techniques have been dramatic in the last 10 years. The goal of this study was to evaluate the age-adjusted in-hospital mortality rate in patients undergoing percutaneous coronary intervention (PCI) using a large database.

Methods: The Nationwide Inpatient Sample (NIS) database was utilized to calculate the age-adjusted mortality rate for PCI from 1988 to 2004 in patients over the age of 40 retrospectively. Specific ICD-9- CM codes for PCI were used for this study. Demographic data were also analyzed and adjusted for age.

Results: The mean age for these patients was 71.56 +/- 10.59 years (53.55% male). From 1988 to 1995, the age-adjusted mortality rate was stable. However, after 1995 the age-adjusted mortality rate showed persistent decline to the lowest level in 2004. (In 1988, age-adjusted mortality rate was 75.43 per 100,000 [95% CI = -7.88-158.76], in 1995, 66.83 per 100,000 [95% CI = 24.62-109.050] and in 2004, 38.38 per 100,000 [95% CI 19.53- 57.22]; p < 0.01). Total death also declined from 1.8% to 1.2%. This trend was similar across gender and ethnicities except for Asians. Furthermore, minorities and women had persistently higher mortality in comparison to males and Caucasians.

Conclusion: The age-adjusted in-hospital mortality rate from PCI was steady until 1995 and declined to its lowest level in 2004. Despite this decline, racial and gender disparity in regard to mortality persisted over the study years.

Download full-text PDF

Source

Publication Analysis

Top Keywords

mortality rate
24
age-adjusted mortality
16
in-hospital mortality
12
100000 [95%
12
mortality
10
patients undergoing
8
undergoing percutaneous
8
percutaneous coronary
8
coronary intervention
8
higher mortality
8

Similar Publications

Burns carry a large surface area, varying in shapes and depths, and an elevated risk of infection. Regardless of the underlying etiology, burns pose significant medical challenges and a high mortality rate. Given the limitations of current therapies, tissue-engineering-based treatments for burns are inevitable.

View Article and Find Full Text PDF

Purpose: Xylazine has been associated with necrotic soft tissue wounds that have placed a challenging burden on patients who inject drugs in the Philadelphia region's health care system over the last few years. An analysis of our initial experience is being presented to guide future treatment and directions for future research.

Methods: A retrospective review of 55 patients with patient-reported xylazine use and associated upper-extremity wounds at a single institution was performed.

View Article and Find Full Text PDF

Objective: Clazosentan is a recently approved endothelin receptor antagonist indicated for the prevention of vasospasm and related complications following aneurysmal subarachnoid hemorrhage (aSAH). To date, no direct, head-to-head comparison between clazosentan and nimodipine has been conducted. In this study, we indirectly assessed the efficacy and safety of these two drugs in preventing vasospasm and its associated outcomes after aSAH.

View Article and Find Full Text PDF

Introduction: Unmet health care needs are seen as a key indicator of equity in access to health care. With younger people, they can lead to poorer health outcomes in adulthood, and in older people they can be associated with an increased risk of mortality. The presence of a disability is considered a risk factor for unmet needs.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!